GNH USA

Europe — EMA

Ipratropium Steri-Neb Norton Healthcare

GNH USA supplies Ipratropium Steri-Neb (Ipratropium bromide), a bronchodilator for COPD, asthma and bronchospasm. Request a quote for global supply.

Ipratropium Bromide

Request sourcing

1
Pack/s

What is Ipratropium Bromide?

Ipratropium bromide, the active ingredient in Ipratropium Steri-Neb Norton Healthcare, is an anticholinergic (muscarinic antagonist) presented as a nebulizer solution for inhalation use. It treats bronchospasm, chronic obstructive pulmonary disease (COPD) and asthma in patients requiring bronchodilation.

GNH USA supplies Ipratropium Steri-Neb Norton Healthcare as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Ipratropium Bromide used for?

Ipratropium bromide is used to manage airway obstruction in respiratory disease states.

COPD: improves airflow and reduces the frequency of exacerbations. Asthma: provides bronchodilation and relieves bronchospasm. Bronchospasm (any cause): rapidly relaxes airway smooth muscle to ease breathing.

What are the side effects of Ipratropium Bromide?

Common Side Effects: - Dry mouth - Cough or throat irritation - Headache - Dizziness - Nausea - Taste alteration

Serious or Rare Side Effects: - Paradoxical bronchospasm - Severe allergic reaction (anaphylaxis) - Angioedema - Tachycardia or palpitations - Urinary retention - Acute glaucoma exacerbation

What precautions apply to Ipratropium Bromide?

Before using ipratropium bromide, consider the following precautions.

Assess renal function: adjust use in severe renal impairment. Monitor anticholinergic load: watch for dry mouth, constipation, urinary retention. Caution in glaucoma: may worsen intra‑ocular pressure. Avoid in known hypersensitivity to ipratropium or formulation components. Evaluate cardiovascular status: may cause tachycardia. Store at room temperature: keep in original container, protect from light and moisture.

What does Ipratropium Bromide interact with?

Ipratropium bromide may interact with other medications.

Major Interactions (Avoid): - Concomitant use with other anticholinergic inhalers (e.g., tiotropium) – increased anticholinergic side effects. - Use with ophthalmic anticholinergics – heightened systemic anticholinergic burden.

Moderate Interactions (Monitor Closely): - Beta‑2 agonists – additive bronchodilation; monitor for excessive tremor. - Theophylline – may increase risk of tachyarrhythmias. - ACE inhibitors – may exacerbate cough. - Antihistamines – can enhance anticholinergic effects.

Frequently asked questions

What conditions is Ipratropium Steri-Neb used for?+
Ipratropium Steri-Neb is prescribed to manage chronic obstructive pulmonary disease (COPD), asthma and other forms of bronchospasm. It works as a bronchodilator to relax airway muscles, improve airflow, and reduce mucus production, helping patients breathe more easily during acute episodes or as part of long‑term maintenance therapy.
How does ipratropium bromide work in the lungs?+
Ipratropium bromide blocks muscarinic M3 receptors on airway smooth muscle, preventing acetylcholine from causing bronchoconstriction. By inhibiting this signal, the drug reduces airway resistance, limits mucus secretion, and promotes smoother airflow, which alleviates symptoms of bronchospasm and improves breathing in COPD and asthma patients.
What is the usual dose of Ipratropium Steri-Neb?+
The dosage of Ipratropium Steri-Neb is determined by the prescribing clinician based on the patient’s condition, severity, and response to therapy. The prescriber will specify the volume of nebulizer solution to be administered, the frequency of dosing, and any adjustments needed for renal function or concurrent medications.
Is Ipratropium Steri-Neb safe during pregnancy or breastfeeding?+
Safety data for ipratropium bromide in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any potential risk to the fetus or infant. Healthcare providers should discuss individual circumstances and consider alternative treatments when appropriate.
How do I order Ipratropium Steri-Neb from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, providing the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, confirming trade or institutional credentials before responding with pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.
How does Ipratropium Steri-Neb compare with other bronchodilators?+
Ipratropium is an anticholinergic bronchodilator, whereas many alternatives such as albuterol are beta‑2 agonists. Ipratropium provides longer‑lasting bronchodilation with fewer systemic cardiac effects, but may cause anticholinergic side effects like dry mouth. Often, clinicians combine it with a beta‑agonist for additive benefit in severe COPD or asthma.
What are the storage requirements for Ipratropium Steri-Neb?+
Store at room temperature: keep the nebulizer solution in its original container, protect it from light, and avoid exposure to moisture. Do not freeze the product. Ensure the storage area remains below 25 °C to maintain stability and efficacy.
How is Ipratropium Steri-Neb administered?+
Ipratropium Steri-Neb is delivered via a nebulizer. The prescribed volume of solution is placed in the nebulizer cup, connected to a compressor that creates an aerosol mist. The patient inhales the mist through a mouthpiece or mask, typically for 5–10 minutes per session as directed by the prescriber.
What are the most serious risks associated with Ipratropium Steri-Neb?+
Serious risks include paradoxical bronchospasm, severe allergic reactions such as anaphylaxis, angioedema, and acute worsening of glaucoma. Patients should be monitored for signs of these events, and treatment should be discontinued immediately if they occur, with appropriate medical intervention provided.
Who should not use Ipratropium Steri-Neb?+
Ipratropium Steri-Neb should be avoided in individuals with known hypersensitivity to ipratropium bromide or any component of the formulation. Caution is advised for patients with narrow‑angle glaucoma, urinary retention, severe renal impairment, or those who have experienced paradoxical bronchospasm with anticholinergic agents.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Ipratropium Bromide
Route
Inhalation Use , Oral Use
Manufacturer
Norton Healthcare Ltd T/A Ivax Pharmaceuticals Uk
Origin
EU

Related products